Ticker League

TTM

$0.69

YoY change

-56.2%

5Y CAGR

-20.5%

Peak year (2023)

$1.76

EPS (Diluted) history chart for Bio-Techne (TECH) from 1989 to 2025

Latest: $0.46

EPS (Diluted) growth chart for Bio-Techne (TECH) from 1989 to 2025

Latest: -56.2%

EPS (Diluted) history table for Bio-Techne (TECH) from 1989 to 2025

  • 2025$0.46-56.2%
  • 2024$1.05-40.3%
  • 2023$1.76+6.0%
  • 2022$1.66+90.8%
  • 2021$0.87-40.0%
  • 2020$1.45+133.9%
  • 2019$0.62-24.4%
  • 2018$0.82+57.7%
  • 2017$0.52-25.7%
  • 2016$0.70-2.8%
  • 2015$0.72-4.0%
  • 2014$0.75-1.3%
  • 2013$0.760.0%
  • 2012$0.760.0%
  • 2011$0.76+4.1%
  • 2010$0.73+5.8%
  • 2009$0.69+4.5%
  • 2008$0.66+22.2%
  • 2007$0.54+17.4%
  • 2006$0.46+15.0%
  • 2005$0.40+25.0%
  • 2004$0.32+18.5%
  • 2003$0.27+68.8%
  • 2002$0.16-20.0%
  • 2001$0.20+25.0%
  • 2000$0.16+60.0%
  • 1999$0.10+3.2%
  • 1998$0.10+38.4%
  • 1997$0.07+26.6%
  • 1996$0.06+26.5%
  • 1995$0.04+24.9%
  • 1994$0.04+16.7%
  • 1993$0.03+100.0%
  • 1992$0.01+20.0%
  • 1991$0.01+66.7%
  • 1990$0.01+134.4%
  • 1989$0.00

EPS (Diluted) values are taken from Bio-Techne's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EPS (Diluted) at Bio-Techne (TECH)

According to Bio-Techne's latest reported financial statements, the company's current diluted EPS (TTM) is $0.69. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

2025's annual diluted EPS for Bio-Techne (TECH) came in at $0.46 – plunged 56.2% year-over-year.

Over 2020–2025 (5 years), Bio-Techne diluted EPS expanded at a -20.5% compound annual rate, with a net decline across the window.

Between 2023 and 2025, Bio-Techne diluted EPS plunged 73.9%, falling from $1.76 to $0.46.

$1.76 stands as the all-time-high annual diluted EPS, posted in 2023, against a low of $0.00 during 1989.

Bio-Techne EPS (Diluted) by Year

Bio-Techne EPS (Diluted) 2025: $0.46

2025's diluted EPS for Bio-Techne came in at $0.46, plunged 56.2% below 2024.

Bio-Techne EPS (Diluted) 2024: $1.05

Bio-Techne posted diluted EPS of $1.05 in 2024, plunged 40.3% below 2023.

Bio-Techne EPS (Diluted) 2023: $1.76

In 2023, Bio-Techne reported diluted EPS of $1.76, grew 6.0% from 2022. This figure represents the highest annual value in the available history.

Bio-Techne EPS (Diluted) 2022: $1.66

Bio-Techne diluted EPS in 2022 was $1.66, surged 90.8% from 2021.

Bio-Techne EPS (Diluted) 2021: $0.87

Bio-Techne diluted EPS in 2021 was $0.87.

See more financial history for Bio-Techne (TECH). Or calculate EPS yourself.

Sector peers by EPS (Diluted)

Healthcare peers of Bio-Techne (TECH), ranked by their latest diluted EPS

Frequently asked questions